Salivary CD44 and Total Protein Levels to Detect Risk for Oral and Oropharyngeal Cancer Recurrence: A Nonrandomized Clinical Trial
Document Type
Article
Publication Title
JAMA Otolaryngology - Head and Neck Surgery
First Page
843
Last Page
850
DOI
https://doi.org/10.1001/jamaoto.2024.2490
Publication Date
Fall 10-1-2024
Recommended Citation
Franzmann EJ, Qi Y, Peifer S, Messer K, Messing B, Blanco RG, Khan Z, Fahkry C, Coffey C, Califano J 3rd. Salivary CD44 and Total Protein Levels to Detect Risk for Oral and Oropharyngeal Cancer Recurrence: A Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2024 Oct 1;150(10):843-850. doi: 10.1001/jamaoto.2024.2490. PMID: 39145961; PMCID: PMC11327900.
COinS